MedTrace Logo

Deep Brain Stimulation for Parkinson's Disease: the Globus Pallidus Internus Versus Subthalamic Nucleus

NCT02647372 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-08-17

No results posted yet for this study

Summary

This study provides an evaluation of 30 patients in 3 years, from the Unified Health System (SUS) irrespective of region of the country, signed with clinical Parkinson's disease in its intermediate stage and that the drug therapy is limited by side effects or beneficial effects provided by prior medication no longer be obtained even at high doses and have therefore the indication for treatment with deep brain stimulation.

Conditions

  • Parkinson Disease

Interventions

PROCEDURE

Subthalamic nucleus

Surgery will be performed in 15 patients with DBS target to the subthalamic nucleus

PROCEDURE

Globus pallidus

Surgery will be performed in 15 patients with DBS target to the globus pallidus nucleus

Sponsors & Collaborators

  • University of Sao Paulo

    collaborator OTHER

  • Hospital Sirio-Libanes

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2017-12-31
Completion
2018-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02647372 on ClinicalTrials.gov